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LETTERS
Mexico, Guatemala, and Honduras 
in 2009–2010, our data suggest emer-
gence of the previously rare G9P[4] 
group A rotavirus genotype in these 
countries. Whether the G9P[4] geno-
type becomes the common strain in 
Latin America or elsewhere remains 
to be determined.
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Recently Identified 
Novel Human  
Astroviruses in 
Children with  
Diarrhea, China
To the Editor: Human astro-
viruses (HAstVs), first identified in 
1975, are now considered an impor-
tant cause of viral gastroenteritis, 
predominately infecting children <2 
years of age (1,2). HAstVs are classi-
fied into 8 serotypes. A unique astro-
virus, MLB1 (AstV-MLB1), recently 
was discovered in a fecal sample from 
a child with diarrhea in Australia (3); 
subsequently, at least 6 novel astrovi-
ruses have been discovered from fe-
cal samples, including AstV-MLB2, 
AstV-MLB3, HMO AstV-A/VA2, 
HMO AstV-C/VA1, HMO AstV-B/
VA3, and AstV-VA4 (4–7). The preva-
lence of novel astroviruses in China 
remains unclear.
Fecal specimens were collected 
during July 2010–June 2011 from 723 
children <5 years of age who had acute 
gastroenteritis. Samples were from all 
of 295 eligible children brought for 
care to First Hospital of Lanzhou Uni-
versity (Lanzhou, China) and every 
fifth eligible child (n = 428) brought 
for care on 2 days of the week (Tues-
day and Thursday) at Nanjing Chil-
dren’s Hospital (Nanjing, China). The 
children’s parents provided informed 
consent. The ethics committees of 
both hospitals approved the study.
Nucleic acids were extracted from 
specimens by using the Viral Nucleic 
Acid Extraction Kit II (Geneaid, Tai-
pei, Taiwan). Adenovirus and calici-
viruses were detected by PCR and re-
verse transcription PCR, respectively 
(8). Rotavirus was detected from fecal 
samples by ELISA (Oxoid, Cambridge, 
UK). Primers Mon269/Mon270 de-
tected a region of the capsid gene (449 
bp) from classic HAstV-1–8 by reverse 
transcription PCR (8). Additional as-
trovirus types were detected by using 
primers SF0073/SF0076, amplifying a 
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409-bp fragment of the astrovirus gene 
open reading frame 1b (5). All ampli-
fication products were sequenced and 
analyzed by using the software pack-
age DNAStar (DNAStar, Madison, 
WI, USA). Phylogenetic trees were 
constructed by using the neighbor-join-
ing method and the software program 
MEGA4 (www.megasoftware.net). 
Statistical analyses were performed by 
using SPSS, version 17.0 (SPSS Inc., 
Chicago, IL, USA).
A total of 320 (44.3%) samples 
were positive for rotavirus and 102 
(14.1%), 27 (3.7%), and 32 (4.4%) 
for caliciviruses, adenoviruses, and 
astroviruses, respectively. A total of 
17 positive samples were detected 
with Mon269/Mon270, and an ad-
ditional 15 samples were found with 
primers SF0073/SF0076. Phyloge-
netic analysis revealed that 21 of 
the 32 astrovirus-positive isolates 
were classic HAstV, dominated by 
HAstV-1 (12 samples); 7 samples 
were AstV-MLB1(GenBank acces-
sion nos. JQ673575–JQ673581), and 
4 were AstV-MLB2 or HMOAstV-A 
(2 isolates each) (GenBank accession 
nos. JQ673582–JQ673585). Primers 
SF0073/SF0076 detected 4 classic 
astroviruses that were not detected 
by Mon269/Mon270. We found no 
statistically significant difference 
(χ2 = 1.547, p = 0.214) between the 
detection rates of novel astroviruses in 
Lanzhou and Nanjing. The prevailing 
astrovirus genotypes (classic and 
novel) in both regions were similar. 
Furthermore, the prevalence and 
genotype distribution of classic 
HAstV were similar to those in a 
previous study in China (8).
Rotaviruses were a co-pathogen 
in 14 (43.8%) astrovirus-positive fe-
cal samples. Three samples were 
AstV-MLB1 positive; the remaining 
11 had classic HAstV. Differences 
were noted between seasonality; clas-
sic astrovirus infections (66.7%) oc-
curred during October and December, 
and novel astrovirus infections were 
observed in March, April, May, July, 
and November. However no statisti-
cally significant differences in mean 
age (p = 0.209, Student t test), rate of 
fever and vomiting (p = 0.712 and p 
= 0.472, respectively, Fisher exact 
test), or mean duration and frequency 
of diarrhea (p = 0.231 and p = 0.177, 
respectively, Student t test) were ob-
served between the classic and novel 
astrovirus groups.
Nucleotide sequence analysis 
showed that the AstV-MLB1 isolates 
in this study had 98.64% homology, 
with 99.65% identity at the amino acid 
level in open reading frame 1b region. 
Further phylogenetic analysis indicated 
that AstV-MLB1 viruses were closely 
related to AstV-MLB1 HK05, with 
95%–98% genomic identity, whereas 
AstV-MLB2 was closely clustered with 
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Figure.	Phylogenetic	analyses	of	human	astroviruses,	China.	Construction	of	phylogenetic	
trees	was	based	on	alignment	of	a	region	of	the	open	reading	frame	1b	nucleic	acid	sequence	
(409	bp),	generated	by	the	neighbor-joining	method	with	1,000	bootstrap	replicates.	Each	
strain	from	this	study	is	indicated	by	the	patient	number	(10621012,	10621141,	10621144,	
10621237,	10621246,	10621264,	10621268,	10322603,	10322608,	10322651,	10322706)	
or	 GenBank	 accession	 number	 (JQ673575–JQ673585)	 as	 indicated.	 AstV,	 astrovirus;	
AstV-MLB,	human	astrovirus	MLB;	HAstV,	human	astrovirus;	HMO-A,	B,	C,	human-,	mink-,	
and	ovine-like	astrovirus	species	A,	B	and	C;	AstV-VA,	human	astrovirus	VA.
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the strain CRI41435, sharing 99% se-
quence identity. AstV-MLB1 and AstV-
MLB2 are phylogenetically related to 
the rat astroviruses RS118 and RS126. 
The remaining novel astroviruses, 
10322603 and 10621246, clustered 
closely with human, mink, and ovine 
astrovirus strain NI-295 (Figure).
This study documented that mul-
tiple novel astroviruses circulated si-
multaneously with common human as-
trovirus types in China. The detection 
rates of novel astroviruses, especially 
Ast-MLB1, were higher than in 2 pre-
vious reports (3,4), although lower 
than in a study from Egypt (9). These 
results indicate that multiple novel as-
troviruses are spread worldwide. The 
differences in prevalence may have 
been caused by the geographic and/or 
study cohort differences. The phylog-
eny of astroviruses determined in our 
study basically agrees with previous 
analyses (5), supporting the idea that 
the novel astroviruses are related to 
other animal astroviruses. Additional 
studies using full-genome sequencing 
should be done to clarify the origin of 
the novel astroviruses.
One limitation of this study was 
that no asymptomatic control was in-
cluded. A recent case–control study has 
suggested that AstV-MLB1 was not as-
sociated with diarrhea (10). However, 
other novel astroviruses were not as-
sessed. Further study, especially with 
a large case–control cohort, should be 
initiated to determine the correlation of 
unique astroviruses with gastrointesti-
nal and extraintestinal diseases.
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Call to Action for 
Dengue Vaccine 
Failure
To the Editor: Dengue is one of 
the most widespread infectious dis-
eases globally; transmission now oc-
curs in 128 countries. Although den-
gue virus (DENV) control strategies 
have targeted vector control and dis-
ease surveillance, the development of 
an effective vaccine is the holy grail 
of prevention.
Dengue vaccine development has 
spanned many decades. A candidate 
vaccine (Sanofi Pasteur, Swiftwater, 
PA, USA) containing all 4 DENV se-
rotypes is in advanced clinical testing. 
However, when given to school chil-
dren in Thailand, this live-attenuated, 
tetravalent, dengue–yellow fever 17D 
chimeric virus vaccine showed ma-
jor but incomplete efficacy against 
3 of the 4 DENV serotypes (DENV 
1 [61.2%], DENV-3 [81.3%], and 
DENV-4 [89.9%]) in the intention-to-
treat group but no protection against 
DENV 2, the most pathogenic of the 
DENV serotypes (1).
Two observations from the effi-
cacy trial in Thailand provide insights 
into protective immunity that could 
greatly improve second-generation 
vaccines. The first observation was 
that a single dose of 4 live-attenuated 
chimeric DENVs given subcutane-
ously at a single site failed to raise 
type-specific protective immunity 
against the 4 DENV serotypes, and 
2) doses 2 and 3 of the Sanofi Pas-
teur vaccine given to children over 
a 1-year period failed to improve ef-
ficacy outcomes. These results were 
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